
Christopher A. Barker, MD
Radiation Oncologist
Titles
Vice-Chair, Clinical Research, Department of Radiation Oncology; Director, Skin Cancer and Melanoma Radiation Oncology
Clinical Expertise
Skin Cancer (Melanoma, Squamous Cell Carcinoma, Basal Cell Carcinoma, Merkel Cell Carcinoma, Dermatofibrosarcoma Protuberans, Cutaneous Angiosarcoma, Cutaneous Sarcoma, Adnexal Carcinoma, Sweat Gland Carcinoma, Kaposi Sarcoma); Soft Tissue Sarcomas; Keloid Scar; Eye Cancer; Ocular Melanomas (Melanoma of the Eye), Uveal Melanoma; Orbital Tumors; Breast Cancer; Lymphoma
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Barker accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 212-639-8168 Office Phone
- Speaks English
- New York City
- Memorial Sloan Kettering Westchester West Harrison, NY

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, University of Florida
Residencies
Radiation Oncology - Memorial Sloan Kettering Cancer Center
Fellowships
National Cancer Institute; Memorial Sloan Kettering Cancer Center
Board Certifications
Radiation Oncology
I am a board-certified radiation oncologist who specializes in the treatment of skin cancer (including melanoma) and eye cancer with radiation therapy.
I am one of a few radiation oncologists in the country who focus on these diseases. I work closely with a dedicated team of experts. We use advanced radiation techniques to deliver the best possible care to our patients. Some of these techniques include superficial radiation therapy (SRT), electronic and radioisotope-based brachytherapy, stereotactic radiosurgery, and proton therapy.
A common question patients ask is whether I have seen or helped manage a cancer problem like theirs. The answer is usually yes. At Memorial Sloan Kettering Cancer Center (MSK), our philosophy is to come up with the best solution for even the most rare and challenging problems.
I have been a member of the MSK team since 2006. I see patients at Memorial Hospital in Manhattan and MSK Westchester.
Read more
I am an active biomedical researcher. My goal is to develop more effective cancer treatments using radiation therapy (RT). Prior to joining MSK, I was a Howard Hughes Medical Institute Research Scholar in the Radiation Oncology Branch of the National Cancer Institute. There, I developed an interest in combining cancer medicines with RT to make treatment more effective.
Along with my colleagues in the Immunology Program and the Departments of Medicine, Surgery, and Pathology at MSK, I have developed several clinical trials. Many of these combine novel targeted and immune therapies with radiation therapy for different cancers.
Another major goal of my research is to find better ways to protect our patients from potential side effects of RT. To do this, I work closely with the Medical Physics Department to give more focused forms of RT. I also work with our Dermatology Service to use special types of skin imaging to more precisely guide RT.Some of these new techniques are more convenient for our patients because fewer treatment sessions are required. We have several clinical trials in this area.
My research has been supported by the American Society for Radiation Oncology, the Lymphoma Research Foundation, and the National Institutes of Health. I have authored chapters in major medical textbooks as well as peer-reviewed research studies in journals. These include the New England Journal of Medicine, the Journal of Clinical Oncology, the Journal of the National Cancer Institute, Clinical Cancer Research, Radiation Research, and the International Journal of Radiation Oncology, Biology, and Physics.
As Vice-Chair for Clinical Research, I lead the Department of Radiation Oncology’s clinical research program. This program supports our study of cutting-edge radiation treatments for all types of cancers, as well as targeted and immune therapies with RT. These clinical research studies offer unique opportunities for our patients.
In addition to taking care of patients and conducting research, I teach others about radiation oncology and skin cancer. I frequently give invited presentations on these subjects at national and international meetings.
Outside of work, I spend most of my time with my wife and three children. We enjoy traveling and various sports activities (as participants and spectators!).
At MSK, our philosophy is to come up with the best solution for even the most rare and challenging problems.
-Dr. Barker
Awards and Honors
- Castle Connolly: America's Top Doctors (2023)
- Castle Connolly: New York Magazine Top Doctors (2019-2022)
- Castle Connolly Top Doctors New York Metro Area (2016-2022)
- Super Doctors: New York Super Doctors (2019-2020)
- Super Doctors: New York Rising Stars (2016-2018)
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all External Beam Radiotherapy Service, Manhattan doctors
Clinical Trials
- Clinical Trials Investigated by Dr. Barker
- A Phase II Study of Radiation Therapy and Cemiplimab Immunotherapy for People with Inoperable Skin Cancer
- A Phase II Study of Radiation Therapy Guided by Special Imaging Techniques in People with Basal Cell Skin Cancer
- A Phase II Study of Radiation Therapy with or without Avelumab in People with Advanced Merkel Cell Carcinoma
- A Study of DaRT Radiation Therapy for People With Squamous Cell Carcinoma of the Skin
Read more

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Barker’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Christopher A. Barker discloses the following relationships and financial interests:
-
Castle Biosciences
Provision of Services (uncompensated)
-
Regeneron Pharmaceuticals, Inc.
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].